A recent study showed that an increase in CKMB, along with other cardiac-specific biomarkers (such as CK, myoglobin, troponin, and NT-proBNP), can play a crucial role in identifying patients vulnerable to developing cardiovascular manifestations of COVID-19(17). Here, NPPB is linked to COVID-19.